These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 9521101)
1. Determination and analysis of antigenic epitopes of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2) using synthetic peptides and computer modeling. Piironen T; Villoutreix BO; Becker C; Hollingsworth K; Vihinen M; Bridon D; Qiu X; Rapp J; Dowell B; Lövgren T; Pettersson K; Lilja H Protein Sci; 1998 Feb; 7(2):259-69. PubMed ID: 9521101 [TBL] [Abstract][Full Text] [Related]
2. Immunoreactivity of recombinant human glandular kallikrein using monoclonal antibodies raised against prostate-specific antigen. Eerola R; Piironen T; Pettersson K; Lövgren J; Vehniäinen M; Lilja H; Dowell B; Lövgren T; Karp M Prostate; 1997 May; 31(2):84-90. PubMed ID: 9140120 [TBL] [Abstract][Full Text] [Related]
3. Cross-reactivity of ten anti-prostate-specific antigen monoclonal antibodies with human glandular kallikrein. Corey E; Buhler KR; Vessella RL Urology; 1997 Oct; 50(4):567-71; discussion 571-2. PubMed ID: 9338733 [TBL] [Abstract][Full Text] [Related]
4. Polyclonal and monoclonal antibodies to prostate-specific antigen can cross-react with human kallikrein 2 and human kallikrein 1. Finlay JA; Day JR; Rittenhouse HG Urology; 1999 Apr; 53(4):746-51. PubMed ID: 10197850 [TBL] [Abstract][Full Text] [Related]
5. Structural comparison of prostate-specific antigen and human glandular kallikrein using molecular modeling. Bridon DP; Dowell BL Urology; 1995 May; 45(5):801-6. PubMed ID: 7538242 [TBL] [Abstract][Full Text] [Related]
6. Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivity. Finlay JA; Evans CL; Day JR; Payne JK; Mikolajczyk SD; Millar LS; Kuus-Reichel K; Wolfert RL; Rittenhouse HG Urology; 1998 May; 51(5):804-9. PubMed ID: 9610595 [TBL] [Abstract][Full Text] [Related]
7. Epitope analysis of a prostate-specific antigen (PSA) C-terminal-specific monoclonal antibody and new aspects for the discrepancy between equimolar and skewed PSA assays. Nagasaki H; Watanabe M; Komatsu N; Kaneko T; Dubé JY; Kajita T; Saitoh Y; Ohta Y Clin Chem; 1999 Apr; 45(4):486-96. PubMed ID: 10102908 [TBL] [Abstract][Full Text] [Related]
8. Immunofluorometric assay for sensitive and specific measurement of human prostatic glandular kallikrein (hK2) in serum. Piironen T; Lövgren J; Karp M; Eerola R; Lundwall A; Dowell B; Lövgren T; Lilja H; Pettersson K Clin Chem; 1996 Jul; 42(7):1034-41. PubMed ID: 8674186 [TBL] [Abstract][Full Text] [Related]
9. A structural model for the prostate disease marker, human prostate-specific antigen. Villoutreix BO; Getzoff ED; Griffin JH Protein Sci; 1994 Nov; 3(11):2033-44. PubMed ID: 7535613 [TBL] [Abstract][Full Text] [Related]
10. Production of recombinant PSA and HK2 and analysis of their immunologic cross-reactivity. Lövgren J; Piironen T; Overmo C; Dowell B; Karp M; Pettersson K; Lilja H; Lundwall A Biochem Biophys Res Commun; 1995 Aug; 213(3):888-95. PubMed ID: 7544581 [TBL] [Abstract][Full Text] [Related]
12. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma. Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461 [TBL] [Abstract][Full Text] [Related]
13. Structural investigation of the alpha-1-antichymotrypsin: prostate-specific antigen complex by comparative model building. Villoutreix BO; Lilja H; Pettersson K; Lövgren T; Teleman O Protein Sci; 1996 May; 5(5):836-51. PubMed ID: 8732755 [TBL] [Abstract][Full Text] [Related]
14. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid. Charlesworth MC; Young CY; Miller VM; Tindall DJ J Androl; 1999; 20(2):220-9. PubMed ID: 10232657 [TBL] [Abstract][Full Text] [Related]
15. Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. Rittenhouse HG; Finlay JA; Mikolajczyk SD; Partin AW Crit Rev Clin Lab Sci; 1998 Aug; 35(4):275-368. PubMed ID: 9759557 [TBL] [Abstract][Full Text] [Related]
16. Modeling of prostate specific antigen and human glandular kallikrein structures. Vihinen M Biochem Biophys Res Commun; 1994 Nov; 204(3):1251-6. PubMed ID: 7526861 [TBL] [Abstract][Full Text] [Related]
17. Identification of human glandular kallikrein hK2 from LNCaP cells. Grauer LS; Charlesworth MC; Saedi MS; Finlay JA; Liu RS; Kuus-Reichel K; Young CY; Tindall DJ J Androl; 1996; 17(4):353-9. PubMed ID: 8889697 [TBL] [Abstract][Full Text] [Related]
18. Characterization of prostate-specific antigen binding peptides selected by phage display technology. Ferrieu-Weisbuch C; Michel S; Collomb-Clerc E; Pothion C; Deléage G; Jolivet-Reynaud C J Mol Recognit; 2006; 19(1):10-20. PubMed ID: 16312021 [TBL] [Abstract][Full Text] [Related]
19. Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids. Lövgren J; Valtonen-André C; Marsal K; Lilja H; Lundwall A J Androl; 1999; 20(3):348-55. PubMed ID: 10386814 [TBL] [Abstract][Full Text] [Related]
20. Western blotting analysis of antibodies to prostate-specific antigen: cross-reactivity with human kallikrein-2. Wang TJ; Linton HJ; Rittenhouse HG; Wolfert RL Tumour Biol; 1999; 20 Suppl 1():75-8. PubMed ID: 10628412 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]